Cervical Cancer Prevention | SBRT for Prostate Cancer | Mutant RAS, 12/04/2024

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Stories of Cancer Research: Preventing Cervical Cancer?   Read Dr. Leeya Pinder's story in the NCI Fiscal Year 2026 Annual Plan and Professional Judgment Budget Proposal. Dr. Pinder is an NCI grant recipient whose work focuses on preventing cervical cancer in areas that lack the resources to provide adequate health care, infrastructure, and trained health care providers. Read More Stereotactic Body Radiotherapy (SBRT) Proves Effective for Some Prostate Cancers   In a large clinical trial, men who received a type of radiation therapy called SBRT didn't have a higher risk of their cancer coming back than men treated with other common radiation therapy regimens that are given over longer periods. Read More New Discovery on How Mutant RAS Drives Tumors A new study led by NCI researchers shows that mutant RAS proteins help kick off a series of events involving the transport of specific proteins in the nucleus. These events lead to uncontrolled tumor growth. Read More New Treatment Option for Breast Cancer The Food and Drug Administration recently approved inavolisib (Itovebi) for adults with HR-positive/HER2-negative metastatic breast cancer with an abnormal PIK3CA gene. This new page provides information about inavolisib, including how it works and more details about its approval. Read More   Contact Us   Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892